Clarice Starling, Ph.D.
Computational biologist moving from single-cell and spatial multi-omics into connectome-scale neuroscience.
Curriculum Vitae
Boston, MA
Rev. 2026
220 Harbor Street, Boston, MA 02135·(555) 019-2847·clarice.starling@example.com·Google Scholar

00Profile

Moving from wet-lab immunology into computational neuroscience. I build methods that infer cellular identity, state, and interaction from large, incomplete single-cell and spatial data. Research objective: connect molecular cell identity to circuit structure and function by integrating connectomics with transcriptomics, growing into connectome-constrained circuit models.

01Education

01
Ph.D., Biomedical Sciences
Hangang National University · Seoul, Republic of Korea
Thesis: Mapping Dendritic Cell Heterogeneity Across Chronic Inflammatory Contexts. Advisor: Min-Ho Suh, M.D., Ph.D.
2014–2023
02
M.S., Biomedical Sciences
Hangang National University · Seoul
Thesis: Enhanced LPS-Induced Monocyte Activation by Recombinant Human Soluble CD180.
2012–2014
03
B.S., Genetic Engineering
Suwon Institute of Life Sciences · Suwon
2008–2012

02Research & Professional Experience

01
Postdoctoral Researcher
Nakdong University Wonju College of Medicine · Physiology / Cellular Systems Research Center
Developed deep-learning multimodal-integration models fusing imaging, transcriptomic, and clinical data into single predictive models.
2025–2026
02
Associate Director
Meridian Immune Therapeutics Inc. · Basic Research, Seoul
Built in-house single-cell and spatial transcriptomics analysis code from scratch; led cross-functional NHP (cynomolgus, marmoset) EAE/MS multi-omic studies; oversaw regulatory documentation for an anti-CD25 humanized-antibody program.
2023–2025
03
Researcher
Xenotransplantation Research Center, HNU · Seoul
Rhesus macaque tissue processing, longitudinal immune monitoring, CNS (brain and spinal cord) tissue handling.
2019–2021
04
Research Student, MOSAIC
Multi-Organ Single-cell Atlas of Immune Cells, HNU · Genomic Medicine Institute
Contributed the founding proposal; executed within the funded program (500+ donors across 6 organs): milestone tracking, multi-site QC, multi-PI coordination.
2020–2023

03Selected Publications

Totals
18total17peer-reviewed6first / co-first1under review
01
Reyes M*, Starling C*, Alvarez T*, et al. "Conserved PDE9X short-isoform bias defines pathogenic Th1.17 state across human inflammatory diseases." Nature Immunology IF 27.7 · under review, 2026. UMI-aware BAM-level isoform analysis; scRNA + scTCR + snATAC integration; ML classifier AUC 0.812; 702 samples, 251,055 CD4⁺ T cells.
02
Starling C*, Tanaka Y*, Truong P*, et al. "Immune cell-enriched scRNA-seq unveils infiltrated CD8⁺ T resident memory cells and meningeal lymphatic endothelium in Parkinson's disease." Journal of Neuroimmunology IF 2.9 · 2025. 9,240 cells, 8 immune populations.
03
Starling C*, Delgado J*, Moreau S, et al. "Deciphering Dysfunctional Regulatory T Cells in Vitiligo." Allergy IF 12.6 · 2025.
04
Alvarez J*, Starling C*, et al. "Long-term control of diabetes by a baricitinib-based regimen after allo-islet transplantation in rhesus monkeys." Xenotransplantation IF 3.9 · 2024.
05
Novak L*, Starling C*, et al. "Intra-tumoral heterogeneity and immune escape of melanoma arising from chronic UV photodamage by spatial gene expression." JEADV IF 9.2 · 2022.
06
Starling C*, et al. "mTOR inhibitor-based immunosuppression in allogeneic islet transplantation." Islets IF 2.2 · 2019.
Selected co-author: eBioMedicine (IF 11.1, 2024), JEADV (IF 9.2, 2024), Current Diabetes Reports (IF 4.2, 2021).

04Technical Skills

01
Single-cell & spatial
scRNA-seq, scTCR-seq, snRNA/snATAC; Seurat, Scanpy, Squidpy, Monocle3, CellChat/NicheNet; scVI/scANVI, batch integration, consensus NMF; custom UMI-aware BAM-level isoform code (Python); Milo, GLIPH, InferCNV, weighted-LMM/EMM; GeoMx DSP; Olink proteomics.
02
ML / DL / AI
Python (scikit-learn, XGBoost/LightGBM/CatBoost, PyTorch); AUC-validated classifiers; VAE/GAN/GNN; multimodal DL integration (imaging + transcriptomic + clinical); AlphaFold2/3, ProteinMPNN, DiffDock, MolFormer; Linux, R/RStudio, Git.
03
Experimental
10x 5′/3′ scRNA + scTCR libraries; high-dimensional flow cytometry (up to 24 markers); brain/CNS immune profiling; IHC/IF (frozen and FFPE); two-photon microscopy; NHP CNS tissue (rhesus, cynomolgus, marmoset); EAE/MS and islet-transplant models.

05Awards, Patents & Scholarships

01
Antagonistic Anti-CD25 Humanized Antibody · Patent 1020240091845
2024
02
Immunosuppression Composition with PI3K Inhibitor · Patent 1020143496217
2019
03
Grand Prize, AI Builders Hackathon (Project Nova)
2024
04
Grand Prize, Metro Innovation Workathon
2023
05
Best Poster, American Transplant Congress, Chicago
2017
06
NRF Ph.D. Scholarship · BK21 Plus · HNU Dean's Lecture & Research Support
2014–2020

06References

01
Min-Ho Suh, M.D., Ph.D. Professor, HNU College of Medicine; CEO/CSO, Meridian Immune. Ph.D. advisor. mhsuh@hangang.ac.kr
02
Ji-Won Baek, M.D., Ph.D. Assistant Professor, HNU Microbiology & Immunology / IBRI. Computational co-corresponding. jwbaek@hangang.ac.kr
03
Dae-Ho Yoon, Ph.D. Professor, Physiology, Nakdong University Wonju College of Medicine. Recent research supervisor. dhyoon@nakdong.ac.kr